XENCOR INC (XNCR) Stock News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Mentions: MBRX PTIX AVGR MBX ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Mentions: NBY AZTR OGEN EYPT ...

Xencor to Participate at Upcoming Investor Conferences

Xencor Reports Third Quarter 2024 Financial Results

Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease

Xencor Presents Preclinical Data on XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, to be Developed for Patients with Inflammatory Bowel Diseases

Xencor Announces Upcoming Change to Board of Directors

XNCR Stock Earnings: Xencor Misses EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Xencor (NASDAQ:XNCR) just reported results for the second quarter of 2024.Xenco...

XNCR Stock Earnings: Xencor Misses EPS, Beats Revenue for Q2 2024

XNCR stock results show that Xencor missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Xencor Announces Pricing of $175 Million Public Offering of Common Stock

Xencor Announces Proposed Public Offering of Common Stock

Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs

Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024

Xencor Reports Second Quarter 2024 Financial Results

Xencor Regains CD20 x CD3 Bispecific T-Cell Engager

XNCR Stock Earnings: Xencor Misses EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Xencor (NASDAQ:XNCR) just reported results for the first quarter of 2024.Xencor...

XNCR Stock Earnings: Xencor Misses EPS, Misses Revenue for Q1 2024

XNCR stock results show that Xencor missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Xencor Reports First Quarter 2024 Financial Results

Xencor Appoints Bart Cornelissen as Chief Financial Officer

Xencor to Present at Upcoming Investor Conferences

Xencor stock slips as Piper cuts on patient death in study

Xencor (XNCR) stock fell as Piper Sandler downgraded the stock citing a death in a mid-stage trial for its prostate cancer drug, vudalimab. Read more here.